Author

Liyun Ni 1

1 Gilead Sciences, Inc,Foster City,United States

EXPOSURE-RESPONSE RELATIONSHIPS FOR EFFICACY AND SAFETY OF FILGOTINIB AND ITS METABOLITE GS-829845 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

Amy Meng, Chia-Hsiang Hsueh, Liyun Ni, Cara Nelson, Chohee Yun

Item 1 - 1 / 1
1